These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias. Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190 [TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing. Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220 [TBL] [Abstract][Full Text] [Related]
11. Possible case of procainamide-induced intrahepatic cholestatic jaundice. Chuang LC; Tunier AP; Akhtar N; Levine SM Ann Pharmacother; 1993 Apr; 27(4):434-7. PubMed ID: 8477118 [TBL] [Abstract][Full Text] [Related]
12. Procainamide-induced incessant supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Eldar M; Ruder MA; Davis JC; Abbott JA; Seger J; Griffin JC; Scheinman MM Pacing Clin Electrophysiol; 1986 Sep; 9(5):652-9. PubMed ID: 2429270 [TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Stambler BS; Wood MA; Ellenbogen KA Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896 [TBL] [Abstract][Full Text] [Related]
14. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Fenster PE; Comess KA; Marsh R; Katzenberg C; Hager WD Am Heart J; 1983 Sep; 106(3):501-4. PubMed ID: 6881022 [TBL] [Abstract][Full Text] [Related]
15. Procainamide hydrochloride sensitivity. Manifested by fever and chills. Shapiro MS; Teitler A; Grob D Minn Med; 1973 Dec; 56(12):1041-4. PubMed ID: 4271436 [No Abstract] [Full Text] [Related]
16. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia. Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498 [TBL] [Abstract][Full Text] [Related]
19. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide. Widerhorn J; Sager PT; Rahimtoola SH; Bhandari AK Pacing Clin Electrophysiol; 1991 Mar; 14(3):420-6. PubMed ID: 1708872 [TBL] [Abstract][Full Text] [Related]
20. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy. Hallak M; Neerhof MG; Perry R; Nazir M; Huhta JC Obstet Gynecol; 1991 Sep; 78(3 Pt 2):523-5. PubMed ID: 1870815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]